Victoria Ebiana
Incyte (United States) · 20 works · 1,334 citations · h-index 13
Top works
- Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
- Controversies in Neuro-Oncology
- Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
- OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC
- OA14.01 KEYNOTE-024 3-Year Survival Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer
- Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study
- Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042
- Retracted: First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset
- Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
- The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma
- First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*
- Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine
- Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
- Ischemic Stroke in a Patient with Parry–Romberg Syndrome
- 134P A phase I study exploring the safety and tolerability of the small molecule PD-L1 inhibitor INCB099318 in select advanced solid tumors
- A phase 1 study of the small-molecule PD-L1 inhibitor INCB099280 in select advanced solid tumors: Updated safety, efficacy, and pharmacokinetics (PK) results.
- Ischemic stroke in a patient with Parry-Romberg syndrome (P4.064)
- P2‐353: Reducing the availability of soluble Aβ halts progression of cerebral amyloid angiopathy in transgenic mice
- Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation
- 155P A phase I study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor INCB099280 in select advanced solid tumors